Correlation Between Pasithea Therapeutics and Catalent

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Catalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Catalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Catalent, you can compare the effects of market volatilities on Pasithea Therapeutics and Catalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Catalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Catalent.

Diversification Opportunities for Pasithea Therapeutics and Catalent

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pasithea and Catalent is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Catalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalent and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Catalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalent has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Catalent go up and down completely randomly.

Pair Corralation between Pasithea Therapeutics and Catalent

Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to generate 47.72 times more return on investment than Catalent. However, Pasithea Therapeutics is 47.72 times more volatile than Catalent. It trades about 0.17 of its potential returns per unit of risk. Catalent is currently generating about 0.03 per unit of risk. If you would invest  2.99  in Pasithea Therapeutics Corp on August 27, 2024 and sell it today you would lose (0.99) from holding Pasithea Therapeutics Corp or give up 33.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy52.02%
ValuesDaily Returns

Pasithea Therapeutics Corp  vs.  Catalent

 Performance 
       Timeline  
Pasithea Therapeutics 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Pasithea Therapeutics Corp are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Pasithea Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Catalent 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Catalent are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable essential indicators, Catalent is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pasithea Therapeutics and Catalent Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pasithea Therapeutics and Catalent

The main advantage of trading using opposite Pasithea Therapeutics and Catalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Catalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalent will offset losses from the drop in Catalent's long position.
The idea behind Pasithea Therapeutics Corp and Catalent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world